Keeping what you built
Protect the intensity, cut the rest: in small trials over 12-15 weeks, strength held on one session a week, VO2max on two days a week or on sessions cut by up to two thirds but not on easier ones, and sprint on one weekly strength session; stopping costs VO2max within weeks and strength more slowly
The question it answers
"I have a busy month (exams, work, a new baby, the race season) — what is the least I can do and not lose it?" and "how fast do I lose it if I stop?"
Default (what to prescribe first)
Decision
| Quality | Least that held it | Not enough | How long it was tested |
|---|---|---|---|
| Strength | 1 session a week (REF-1628, REF-1136) | 1 session every 2 weeks: held 6 weeks, then lost part (−4.4% 1RM by week 12, REF-1136); strength and sprint fell in footballers (REF-1628) | 12 weeks |
| Muscle size, younger adults | a third or a ninth of the training dose (REF-1622) | — | 32 weeks |
| Muscle size, older adults | not found: neither a third nor a ninth held it (REF-1622); the review suggests up to 2 sessions and 2-3 sets per exercise a week (REF-587, C+) | a ninth and a third (REF-1622) | 32 weeks |
| VO2max | 2 days a week, same intensity and length (REF-1219); sessions cut by ⅓ or ⅔ (REF-1220) | work rate cut by ⅓ or ⅔ (REF-951) | 15 weeks |
| Long endurance (2 h+) | sessions cut by a third (REF-1220) | sessions cut by two thirds (−10%, REF-1220); work rate cut by a third (−21%, REF-951) | 15 weeks |
| 40-m sprint | 1 strength session a week (REF-1628) | 1 every 2 weeks (REF-1628) | 12 weeks |
| Heat acclimation | 2 sessions a week of 60 min heated exercise to hyperthermia: heart rate in the heat 23 bpm below none, read by the authors as maintained (REF-1246, B-, 24 trained men) | none (about 2.5% of the acquired adaptation lost a day, REF-1197); 1 a week not clearly different from none (p = 0.112, REF-1246) | 8 weeks |
How to progress / periodise
When NOT to use it / red flags
What the evidence does and does not show
Evidence gaps
How this entry was checked and changed
the maintenance doses rest on small reduced-training trials, all but REF-1136 read from abstracts with group sizes or methods missing and most in study-trained subjects (B: REF-1219, REF-1220, REF-951, REF-1628, REF-1136; B+: REF-1622, a randomised trial read from its abstract; B+: REF-1133, single small studies in endurance athletes; heat: REF-1246, B-, and REF-1197, B+), a meta-analysis of training cessation (REF-375, B+) and narrative reviews (REF-587, REF-374, C+); the doses held over 8 to 32 weeks, so the rules are not shown beyond that